Swixx BioPharma

Swixx BioPharma aims to fully replace the subsidiaries or business units of biopharmaceutical, over-the-counter drug, and medical device multinational companies in these countries or in the CEE therapeutic fields. With over 550 employees, Swixx BioPharma's sales are expected to exceed 220 million euros in 2020, making it the largest ethical pharmaceutical agent serving research-based biopharmaceuticals in the CEE region. The company is composed of a team proficient in access management and medical expertise, dedicated to bringing modern medicines to people in Central and Eastern Europe.